Hemopatch
Hemopatch is a medical device with 18 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 12 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
2
Mid Stage
4
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
12 of 12 finished
0.0%
0 ended early
1
trials recruiting
18
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Hemopatch Safety and Efficacy Evaluation Versus Standard Practice for Sealing the Dura in Cerebrospinal Fluid Leaks
The Effectiveness of Hemopatch® in the Reduction of Post-surgical Serous Drainage
A Phase II Prospective, Single Blinded, Randomized Trial of Hemopatch Compared to Standard Techniques to Achieve Air Leak Control After Complex Thoracic Surgical Procedures
Hemopatch Versus Axillary Drainage After Axillary Lymphadenectomy
Hemopatch Performance Evaluation: A Prospective Observational Registry
Clinical Trials (18)
Hemopatch Safety and Efficacy Evaluation Versus Standard Practice for Sealing the Dura in Cerebrospinal Fluid Leaks
The Effectiveness of Hemopatch® in the Reduction of Post-surgical Serous Drainage
A Phase II Prospective, Single Blinded, Randomized Trial of Hemopatch Compared to Standard Techniques to Achieve Air Leak Control After Complex Thoracic Surgical Procedures
Hemopatch Versus Axillary Drainage After Axillary Lymphadenectomy
Hemopatch Performance Evaluation: A Prospective Observational Registry
Hemopatch to Prevent Lymphatic Leak After Robotic Prostatectomy and Pelvic Lymph Node Dissection
Use of Hemopatch as a Sealant at the Pancreaticojejunostomy After Pancreatoduodenectomy
Hemopatch Versus No Hemopatch (Renal Transplant)
Intra-operative Application of HEMOPATCH to the Pancreatic Stump to Prevent Post-operative Pancreatic Fistula Following Distal Pancreatectomy
Evaluating Hemopatch in Reducing Seroma Related Complications Following Axillary Lymph Node Dissection: a Pilot Study
Effectiveness Novel Tissue Sealant, Prevention Prolonged Air Leak (PAL) After Lung Resection
Hemopatch as a Tool to Prevent Biliary Fistula in Liver Surgery.
Hemopatch Compared to TachoSil in Postoperative Air Leak Duration After Pulmonary Resection
Effectiveness of the Use of the New Hemostatic Patch Hemopatch ® in Patients Undergoing Surgical Liver Resection
Standard of Care Versus Hemopatch® During Liver Resection
Efficacy and Tolerability of Hemopatch After Hepatic Resection
Prospective Clinical Trial of the Hemopatch Topic Hemostatic in Cardiac Surgery
Reinforcement of Rectal Anastomosis-RORA
All 18 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 18